Los Angeles Capital Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-22,222
| Closed | -$453K | – | 1119 |
|
|
2024
Q4 | $453K | Sell |
22,222
-5,718
| -20% | -$117K | ﹤0.01% | 834 |
|
|
2024
Q3 | $814K | Sell |
27,940
-24,923
| -47% | -$726K | ﹤0.01% | 715 |
|
|
2024
Q2 | $1.23M | Sell |
52,863
-2,749
| -5% | -$63.8K | ﹤0.01% | 584 |
|
|
2024
Q1 | $1.14M | Buy |
55,612
+9,054
| +19% | +$186K | ﹤0.01% | 655 |
|
|
2023
Q4 | $999K | Buy |
46,558
+556
| +1% | +$11.9K | ﹤0.01% | 670 |
|
|
2023
Q3 | $949K | Buy |
46,002
+1,046
| +2% | +$21.6K | ﹤0.01% | 659 |
|
|
2023
Q2 | $1.33M | Buy |
44,956
+26,449
| +143% | +$781K | 0.01% | 586 |
|
|
2023
Q1 | $426K | Sell |
18,507
-2,395
| -11% | -$55.2K | ﹤0.01% | 901 |
|
|
2022
Q4 | $581K | Sell |
20,902
-21,839
| -51% | -$607K | ﹤0.01% | 854 |
|
|
2022
Q3 | $1.31M | Sell |
42,741
-1,178
| -3% | -$36.2K | 0.01% | 609 |
|
|
2022
Q2 | $1.29M | Buy |
43,919
+1,667
| +4% | +$49.1K | 0.01% | 642 |
|
|
2022
Q1 | $1.36M | Buy |
42,252
+1,160
| +3% | +$37.3K | 0.01% | 654 |
|
|
2021
Q4 | $1.83M | Sell |
41,092
-430
| -1% | -$19.2K | 0.01% | 538 |
|
|
2021
Q3 | $2.1M | Buy |
41,522
+8,090
| +24% | +$408K | 0.01% | 524 |
|
|
2021
Q2 | $2.62M | Buy |
33,432
+16,457
| +97% | +$1.29M | 0.01% | 523 |
|
|
2021
Q1 | $969K | Sell |
16,975
-4,101
| -19% | -$234K | ﹤0.01% | 911 |
|
|
2020
Q4 | $1.77M | Buy |
21,076
+12,025
| +133% | +$1.01M | 0.01% | 705 |
|
|
2020
Q3 | $324K | Sell |
9,051
-6,829
| -43% | -$244K | ﹤0.01% | 1246 |
|
|
2020
Q2 | $384K | Sell |
15,880
-4,170
| -21% | -$101K | ﹤0.01% | 1211 |
|
|
2020
Q1 | $351K | Buy |
+20,050
| New | +$351K | ﹤0.01% | 1012 |
|